HHS:NASDAQHarte Hanks, Inc. Analysis

Harte Hanks trades at $2.51, barely above its computed support of $2.45 and well below the 20‑day SMA of $2.54, the 50‑day SMA of $2.67, and the 200‑day SMA of $3.01, indicating a bearish price positioning. Technical indicators reinforce the downside bias: RSI sits at 44.6 (just under neutral), MACD is bearish, and volume is on a decreasing trend, suggesting weak buying pressure. Fundamentally, the company reports a 10% revenue decline, negative operating (‑2.44%) and profit margins (‑0.67%), and a trailing EPS of –$0.14, with operating cash flow and free cash flow both negative, highlighting cash‑flow strain. The balance sheet shows $22.0 M of debt versus $4.5 M of cash, yielding a debt‑to‑equity ratio over 100%, while the forward PE of 2.35 is dramatically below the industry average of 31.2, making the stock appear cheap but potentially a value trap. Volatility is high at 37.7% over the past 30 days and the beta of 0.62 suggests limited market correlation, yet the small market cap of $18.6 M and thin average volume raise liquidity concerns. No dividend is paid and recent news provides no material catalyst, leaving the outlook dependent on an operational turnaround that is currently uncertain.